Cite

    Wang, Y. et al. (n.d.). Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats. Journal of hypertension. 34 (5), pp. 993-1004. [Online].